An example how long granting one may take/ is from another con cious BIO company /
SYDNEY, AUSTRALIA - 15 July 2020 - Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the
“Company”) announces the grant of patent no. 10,711,060 entitled “Antibody molecules to LAG-3 and
uses thereof” by the United States Patent and Trade Mark Office.
This new United States patent is directed to embodiments of LAG525, a humanised form of Immutep’s
IMP701 antibody which is out-licensed to Novartis AG. In particular, the patent is directed to nucleic acid
molecules that code for the LAG525 antibody, to expression vectors and host cells that comprise these
nucleic acids, and to methods of producing the LAG525 antibody by culturing the host cells of the
invention.
The application was originally filed as a second divisional application and this grant follows the grant of
the firstSYDNEY, AUSTRALIA - 15 July 2020 - Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the“Company”) announces the grant of patent no. 10,711,060 entitled “Antibody molecules to LAG-3 anduses thereof” by the United States Patent and Trade Mark Office.This new United States patent is directed to embodiments of LAG525, a humanised form of Immutep’sIMP701 antibody which is out-licensed to Novartis AG. In particular, the patent is directed to nucleic acidmolecules that code for the LAG525 antibody, to expression vectors and host cells that comprise thesenucleic acids, and to methods of producing the LAG525 antibody by culturing the host cells of theinvention.The application was originally filed as a second divisional application and this grant follows the grant ofthe first divisional application, as announced in March 2018. The patent is co-owned by Novartis AG andImmutep S.A.S. and will expire on 26 March 2035 (including a 13 day patent term adjustment). The patent is co-owned by Novartis AG and
Immutep S.A.S. and will expire on 26 March 2035 (including a 13 day patent term adjustment).
- Forums
- ASX - By Stock
- Ann: Qubit control measurements commence
An example how long granting one may take/ is from another con...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AXE (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
-0.010(3.85%) |
Mkt cap ! $63.71M |
Open | High | Low | Value | Volume |
26.0¢ | 26.0¢ | 24.5¢ | $3.548K | 14.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 10738 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 1500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 10738 | 0.250 |
2 | 34212 | 0.245 |
2 | 14170 | 0.240 |
7 | 79541 | 0.235 |
7 | 173986 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 1500 | 1 |
0.265 | 93894 | 2 |
0.270 | 36693 | 3 |
0.275 | 11728 | 3 |
0.280 | 30000 | 2 |
Last trade - 15.32pm 23/08/2024 (20 minute delay) ? |
Featured News
AXE (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online